The FDA approved product is: Zuranolone (Zurzuvae) for post-partum depression
This is a presentation on the hisotry and development of Zuranolone for PPD. The amount of words or slides do not matter. I just need you to do reserach on the following items:
– For Pharmacovigilance: identify post-marketing surveillance along with the reasoning behind the continued monitoring.
–> please do not discuss REMS or the black boxed warning as I already included that into my presentation.
– For Medical Affairs/Medical Information: Identify post-marketing/phase IV trials that are done or currently undergoing. Present brief summaries of relevant post-marketing trials and why are they relevant for the drug.
ANSWER THESE QUESTIONS FOR MEDICAL AFFAIRS:
-Review the patent, prescriber information, clinical trials, NDA and marketing materials for Zuranonlone. Can you step back to see how medical affairs would have put it all together and directed/influenced/collaborated on messaging related to therapeutic applications?
– Find at leasr two available clinical trials about Zuranolone : How many scientists, researchers, clinicians or KOL’s appear in connected studies by the same sponsor? Work backward to infer the strategy used by the medical director and others.
— number of sources not specified but use at least 2
— CITATION IN AMA 11TH EDITION PLEASE
— DO NOT use ChatGPT because I already tried that and took all the info it could give me